330 results
Page 6 of 17
S-4
a433li1 5uq7tunh3juh
4 Jan 19
Registration of securities issued in business combination transactions
5:05pm
8-K
wrqqjnmvvmjhe li
4 Jan 19
Departure of Directors or Certain Officers
8:45am
425
nncxuzro
8 Nov 18
Business combination disclosure
9:54pm
425
EX-2.1
xcik92ujob9ep3egu
8 Nov 18
Business combination disclosure
6:41am
425
2uz a04glvc
8 Nov 18
Business combination disclosure
6:41am
425
EX-99.1
p4v7n5aat6se028ac
8 Nov 18
Business combination disclosure
6:41am
8-K
EX-2.1
j9iod m5lvn
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
z25d015mbf4uf
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
EX-99.1
b3dpbudr8wk36t
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
EX-1.1
5em4bja
13 Oct 17
Entry into a Material Definitive Agreement
12:00am
424B5
1zzd1
13 Oct 17
Prospectus supplement for primary offering
12:00am